结合临床与剂量学特征构建PBS质子治疗放射性视神经病变NTCP模型
该回顾性研究在颅底及头颈癌质子治疗队列中,比较了Lyman-Kutcher-Burman与泊松NTCP模型,并纳入年龄、肿瘤累及、高血压、性别等临床变量。结果显示加入临床变量后模型性能显著提升;视路最大剂量仍是最直观风险因素,但超过一定剂量阈值后患者临床特征成为RION发生的决定因素,并观察到体积效应趋势。
要点
- 视路最大剂量是RION最直观的风险因素。
- 超过一定剂量阈值后,临床患者特征成为RION发生的决定因素。
- 加入年龄、肿瘤累及、高血压、性别等变量后模型性能显著提升。
核心结论
- 视路最大剂量是RION最直观的风险因素,但超过一定剂量阈值后临床患者特征对RION发生起决定作用。
- 观察到体积效应趋势,若被证实则高精度质子治疗可能使RION高临床风险患者获益。
研究设计与样本
- 回顾性研究,采用铅笔束扫描质子治疗颅底及头颈癌患者队列。
- 比较常见现象学NTCP模型与纳入临床特征的多变量分析,以探索质子治疗特异性风险因素。
主要发现
- Lyman-Kutcher-Burman与泊松模型对该数据集的预测能力有限。
- 加入年龄、肿瘤累及、高血压或性别等临床变量后模型性能显著提升。
临床怎么用
- 质子治疗计划评估RION风险时,除视路最大剂量外应结合年龄、肿瘤累及、高血压、性别等临床特征。
- 对RION高临床风险患者,可考虑采用质子治疗等高精度放疗技术以利用潜在体积效应获益。
局限性
- 本研究为回顾性研究。
- RION为罕见并发症,队列事件数可能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiation-induced optic neuropathy (RION) is a rare, yet severe complication following radiation therapy for brain, head and neck, or skull-base tumors. Although several risk factors, such as age, metabolic syndrome, and delivered dose, have been identified, we aimed at expanding the understanding of the mechanisms of interplay regarding dosimetry and patient variables leading to the onset of RION with a focus on proton therapy. METHODS AND MATERIALS: In this retrospective study, we have investigated proton-specific risk factors by comparing common phenomenological normal tissue complication probability models with a multivariate analysis that includes clinical features on a cohort of patients with skull-base and head and neck cancer treated with pencil beam scanning. RESULTS: Although predictive power of the Lyman-Kutcher-Burman and Poisson models was limited for this data set, the addition of clinical variables such as age, tumor involvement, hypertension, or sex remarkably increased model performance. CONCLUSIONS: Based on our assessment, the maximum dose in the optical apparatus is confirmed the most intuitive risk factor. However, above a certain dose threshold, clinical patient characteristics are the deciding factors for the onset of RION. We observed a tendency toward a volume effect that, if confirmed, would imply a benefit for high precision radiation therapy techniques such as proton therapy for the treatment of patients with high clinical risk for RION.
引用
- Köthe A, van Luijk P, Safai S, et al. Combining Clinical and Dosimetric Features in a PBS Proton Therapy Cohort to Develop a NTCP Model for Radiation-Induced Optic Neuropathy. Int J Radiat Oncol Biol Phys. 2021. PMID: 33421557. doi:10.1016/j.ijrobp.2020.12.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。